DiaCarta Nabs CE-IVD for its Non-Invasive Colorectal Cancer Test

California–based DiaCarta has achieved CE-IVD approval for ColoScapeTM, a colorectal cancer mutation detection kit.

The device is designed to detect clinically validated CRC mutations in DNA extracted from solid tumor, plasma or stool samples.

The device can complete an assay in less than 2.5 hours. — Cynthia Jessup